metformin
AssetSmall moleculeAlso Metformin DR, Glucovance, Metformin XR, Metformin Hydrochloride
Activates AMPK and reduces hepatic gluconeogenesis
- Stage
- Approved
- Modality
- Small molecule
- Target
- Mitochondrial biogenesis (PGC-1α)
- Indications
- 22
- Trials
- 1,347
- Developers
- 12
Indications
22Type 2 diabetes
Approvedaccessdata.fda.gov7 Oct 2026
Aging
Phase 3ACTIVE_NOT_RECRUITINGNCT07475546clinicaltrials.gov7 Oct 2026
Diabetes mellitus
Phase 3COMPLETEDNCT04288778clinicaltrials.gov7 Oct 2026
19 more
- Targets and what it contains6
- Owner and partners12
- Trials1,347
- Evidence for its targets7
- Competitors12
- Aging relevance4
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 43 sources